International Leaders Eurofins and MWH Global Complete Strategic Sale and Services Agreement for MWH Laboratories
Eurofins, (www.eurofins.com) the world leader in analytical testing support to the global environmental sector, announces that it is taking over MWH Laboratories (MWH Labs), the largest, full-service, single-site water testing laboratory in the US, as part of a five-year outsourcing deal with MWH Global, a leading consulting, technical engineering and construction services firm.
Entering into a Preferred Laboratory Services Agreement with MWH whereby MWH selects Eurofins as its preferred partner globally, signifies a collaborative union with utmost benefit to international customers. Located in California with more than 500 clients in the United States and 100 foreign countries, MWH Labs significantly enhances Eurofins water testing footprint and capabilities. MWH generates over USD 15 million revenues with over 100 employees.
For more than 40 years, MWH Labs has earned an industry-leading reputation for high quality testing and regulatory compliance while serving local, state and federal municipal agencies; private water utilities; engineering firms and Fortune 500 companies. With a strong dedication to customer service and method development for emerging contaminants, MWH Labs is the trusted source for a broad range of consistently high-quality water and wastewater tests analyzing for disinfection byproducts, microbiology, organics, inorganics, asbestos and radioactivity.
With more than 39 years of experience in water testing, Ed Wilson, MWH VP and laboratory director, recognizes the value for clients in aligning with quality, customer-focused and growing laboratories such as Eurofins and Eurofins Lancaster Laboratories. "Our primary focus at MWH Labs is to surpass our clients' expectations by developing specialized tests that go beyond standard water quality work through our ongoing method development research program that continually offers more ways to serve" says Mr. Wilson. "Partnering with the Eurofins' extensive network of laboratories coupled with their commitment to expand capabilities further enhance the broad range of services we can deliver to clients, particularly on a global level."
The integration in Eurofins network will allow MWH Labs and its staff to offer the full range of services available from Eurofins' collection of more than 170 laboratories around the world. Behind these expanded services will be a high level of IT capabilities and systems that will allow clients to have convenient access to their data online via secure data portals, 24 hours a day, seven days a week. Eurofins is committed to providing the best laboratory services and client support to its customers and is dedicated to consistently providing the highest level of analytical testing technology available in the industry.
"Bringing MWH Labs level of technical sophistication in drinking water analyses into the Eurofins international portfolio is part of an ongoing strategy to add best-in-class capabilities and ultimately provide the absolute best service to our customers," says Dr. J. Wilson Hershey, chairman of Eurofins Lancaster Laboratories.
Beginning August 1, 2012, MWH Laboratories will become Eurofins Eaton Analytical.
Eurofins Lancaster Laboratories
2425 New Holland Pike
|Phone : 717-656-2300
E-mail : email@example.com
Notes for the editor:
Eurofins - a global leader in bio-analysis
Eurofins Scientific is the world leader in food and pharmaceutical products testing. It is also number one in the world in the field of environmental laboratory services and one of the global market leaders in agroscience, genomics and central laboratory services.
With over 12,000 staff in more than 170 laboratories across 32 countries, Eurofins offers a portfolio of over 100,000 reliable analytical methods for evaluating the safety, identity, composition, authenticity, origin and purity of biological substances and products. The Group provides its customers with high quality services, accurate results in time and expert advice by its highly qualified staff.
Eurofins is committed to pursuing its dynamic growth strategy by expanding both its technology portfolio and its geographic reach. Through R&D and acquisitions, the Group draws on the latest developments in the field of biotechnology and analytical chemistry to offer its clients unique analytical solutions and the most comprehensive range of testing methods.
As one of the most innovative and quality oriented international players in its industry, Eurofins is ideally positioned to support its clients' increasingly stringent quality and safety standards and the expanding demands of regulatory authorities around the world.
The shares of Eurofins Scientific are listed on the NYSE Euronext Paris Stock Exchange (ISIN FR0000038259, Reuters EUFI.PA, Bloomberg ERF FP).
This press release contains forward-looking statements and estimates that involve risks and uncertainties. The forward-looking statements and estimates contained herein represent the judgement of Eurofins Scientific' management as of the date of this release.
These forward-looking statements are not guarantees for future performance, and the forward-looking events discussed in this release may not occur. Eurofins Scientific disclaims any intent or obligation to update any of these forward-looking statements and estimates. All statements and estimates are made based on the data available to the Company as of the date of publication, but no guarantee can be made as to their validity.